Medical Device

submitted by Alicia Juarrero

UCLA, STOCKHOLM UNIVERSITY AND UPPSALA UNIVERSITY

CLICK HERE - Nature Communications - Targeted DNA sequencing and in situ mutation analysis using mobile phone microscopy

bbc.com - by Leo Kelion - January 18, 2017

Scientists have built a DNA-analysing smartphone attachment that is a fraction of the cost of lab-based kit.

The creators of the phone-powered pathology microscope believe it could be mass produced for less than $500 (£406) a unit.

They say it could help doctors treat cancer, tuberculosis and other diseases more effectively than is sometimes possible in the developing world.

But a UK firm says it is developing a more advanced and cheaper alternative.

Details of the peer-reviewed project are published in the journal Nature Communications.

(READ COMPLETE ARTICLE)

From watching the video in the link below, the Arktek vaccine cold storage device is also known as the P6 . . .
http://www.intellectualventures.com/inventions-patents/our-inventions/vaccine-cold-chain-device/

The P6 is not just a container, but an innovative high-tech device.  It is designed to keep vaccines at the appropriate temperatures for a month or more with repeat vaccine retrievals and no need for electricity (using just one initial batch of ice).  The device also has built-in communications and monitoring capability.  The P6 units are able to send live updates, including the units’ GPS positions viewable on interactive maps, the number of days since fresh ice had been added, temperature, and more.  Here are the details . . .
http://www.intellectualventureslab.com/invent/a-story-of-invention-the-passive-vaccine-storage-device

THE WASHINGTON POST by Ariana Eunjung Cha                                                      June 26, 2015

Public health officials may soon be able to screen patients for Ebola at border crossings and hospitals with a finger-prick blood test that takes mere minutes.

The development of the rapid diagnostic test, reported in The Lancet Thursday, represents a significant victory for scientists around the world who have been experimenting over the past year with all manner of vaccines, treatments and other ways of eradicating the virus.

Developing a way of confirming Ebola in a patient has been one of the top priorities. In the early stages the symptoms -- chest pain, cough, nausea -- can look like many other illnesses, making it very difficult for doctors to triage -- to determine who should be quarantined and who to send home. It can often take days or longer for laboratory tests, the current standard, to return a positive or negative result.

AFP                                                                                April  23, 2015
Miami  - US regulators have issued an international recall for a 10-minute Ebola blood test made by a California-based company, saying it has not been proven to work and could put lives at risk.

"A recall has been issued for the LuSys Laboratories, Inc., Ebola Virus One-Step Test Kits because the FDA has not cleared or approved the kits for use or sale," said the Food and Drug Administration in a statement emailed to reporters on Thursday.

"The results obtained from these test kits have not demonstrated to be accurate and should not be used as in vitro diagnostic tests for Ebola infection."

Contacted by AFP, a company representative in San Diego said early trials have shown the test to be 86 percent accurate. The problem with the FDA came down to a labeling error, he said. The equipment had not been properly labeled "for research purposes only."

Read complete story.
http://news.yahoo.com/us-regulators-recall-10-minute-ebola-test-193530081.html;_ylt=AwrC1CmnSjlVNDsAZTDQtDMD;_ylu=X3oDMTByaWg0YW05BGNvbG8DYmYxBHBvcwM4BHZ0aWQDBHNlYwNzcg--